11/09/09 PRSA Healthcare presentation on Integrating Social Media into your organization's PR: How to Satisfy Regulatory & Legal and Still be Credible -- by Betsy Raymond Stevenson and Steve Woodruff
Talk aimed at start up businesses and how they should leverage social platforms to promote themselves and their business - went down great - some sceptics initially - but they changed their minds when they saw its relevancy to their businesses.
Introductory overview of strategic social media, created for the Texas Hospital Association's one-day conference, "Where Social Media and Health Care Meet- Harnessing New Media Tools."
Social Media for Healthcare OrganizationsErica Ayotte
Overview of opportunities, strategies, and tactics for social marketing within healthcare settings. Learn how to create a strategy framework, data and strategy points to use with the C-suite, and tactics for Facebook, Twitter, LinkedIn, Google+, Pinterest, Instagram, and YouTube.
Corporate Social Media Guidelines - Protecting Your Organization From Hidden ...Raul Colon
One wrong move can land you or your company into an unknown abyss. The lack of guidance from Social Media and non-existent controls can cost companies hundreds of thousands or even millions. The hidden risks of not understanding the many channels of Social Media are immeasurable. With a better understanding and some guidance on Social Media Patterns yourself and your company are going to be able to mitigate the arising risks.
Talk aimed at start up businesses and how they should leverage social platforms to promote themselves and their business - went down great - some sceptics initially - but they changed their minds when they saw its relevancy to their businesses.
Introductory overview of strategic social media, created for the Texas Hospital Association's one-day conference, "Where Social Media and Health Care Meet- Harnessing New Media Tools."
Social Media for Healthcare OrganizationsErica Ayotte
Overview of opportunities, strategies, and tactics for social marketing within healthcare settings. Learn how to create a strategy framework, data and strategy points to use with the C-suite, and tactics for Facebook, Twitter, LinkedIn, Google+, Pinterest, Instagram, and YouTube.
Corporate Social Media Guidelines - Protecting Your Organization From Hidden ...Raul Colon
One wrong move can land you or your company into an unknown abyss. The lack of guidance from Social Media and non-existent controls can cost companies hundreds of thousands or even millions. The hidden risks of not understanding the many channels of Social Media are immeasurable. With a better understanding and some guidance on Social Media Patterns yourself and your company are going to be able to mitigate the arising risks.
Presentation to community college presidents at AACC conference in New Orleans, LA in April 2011. Presented by: Kyle Schwarm, Exec Director of the Wis Technical College System marketing consortium and Barb Dreger, Director of College Marketing, Fox Valley Technical College
How To Handle The Responsibilities Of Hipaa, Identity Theft, And Privacy Conc...Ryan Squire
How To Handle The Responsibilities Of Hipaa, Identity Theft, And Privacy Concerns While Introducing New Social Media Technologies as presented by Ryan Squire at the ALI conference on health care in social media 10/5-8/09.
UNF NP Management Conference 2011 Nonprofits and Social Media: An Introduction Georgette Dumont
These are the slides from the NP and Social Media workshop at the UNF Nonprofit Management Conference, September 23, 2011. This is an introduction to some of the widely used social media platforms.
Presentation given for the University of Colorado Career Services on how job seekers can use social media sites such as LinkedIn, Facebook and Twiiter in their job search.
Risks and opportunities for using social media for government transparencyStan Skrabut, Ed.D.
This presentation reviews guidelines that government agencies should follow to ensure laws and regulations are met while providing a communication outlet for citizens.
New FDA Social Media Guidelines 2014: Star Group AnalysisJoshua Spiegel
What does the recent draft guidance from the FDA for social media mean for Pharma brands? Find out what Star Life Sciences thinks, then visit us at starlifebrands.com to see more articles with our thinking.
Social Media Rules for Pharma's FDA-Regulated IndustryPALIO
Originally presented during a Webinar provided by Thompson Interactive on 11/30/11.
http://goo.gl/XL0H4
The social media guidance that the FDA has been promising has yet to arrive, but that should not stop you from getting involved with social media in your company.
A quick overview of what is going on out there with some real life examples for learning.
"Uncertainty can be a Guiding Light"
To truly leverage the power of social networks, Pharma need to understand the principle of open innovation and learn to live with (and take) communication risk.
The FDA will never give crystal clear guidelines on social media. Their existing statements is all the real direction any compnay needs
Presentation to community college presidents at AACC conference in New Orleans, LA in April 2011. Presented by: Kyle Schwarm, Exec Director of the Wis Technical College System marketing consortium and Barb Dreger, Director of College Marketing, Fox Valley Technical College
How To Handle The Responsibilities Of Hipaa, Identity Theft, And Privacy Conc...Ryan Squire
How To Handle The Responsibilities Of Hipaa, Identity Theft, And Privacy Concerns While Introducing New Social Media Technologies as presented by Ryan Squire at the ALI conference on health care in social media 10/5-8/09.
UNF NP Management Conference 2011 Nonprofits and Social Media: An Introduction Georgette Dumont
These are the slides from the NP and Social Media workshop at the UNF Nonprofit Management Conference, September 23, 2011. This is an introduction to some of the widely used social media platforms.
Presentation given for the University of Colorado Career Services on how job seekers can use social media sites such as LinkedIn, Facebook and Twiiter in their job search.
Risks and opportunities for using social media for government transparencyStan Skrabut, Ed.D.
This presentation reviews guidelines that government agencies should follow to ensure laws and regulations are met while providing a communication outlet for citizens.
New FDA Social Media Guidelines 2014: Star Group AnalysisJoshua Spiegel
What does the recent draft guidance from the FDA for social media mean for Pharma brands? Find out what Star Life Sciences thinks, then visit us at starlifebrands.com to see more articles with our thinking.
Social Media Rules for Pharma's FDA-Regulated IndustryPALIO
Originally presented during a Webinar provided by Thompson Interactive on 11/30/11.
http://goo.gl/XL0H4
The social media guidance that the FDA has been promising has yet to arrive, but that should not stop you from getting involved with social media in your company.
A quick overview of what is going on out there with some real life examples for learning.
"Uncertainty can be a Guiding Light"
To truly leverage the power of social networks, Pharma need to understand the principle of open innovation and learn to live with (and take) communication risk.
The FDA will never give crystal clear guidelines on social media. Their existing statements is all the real direction any compnay needs
This presentation was delivered to a webinar sponsored by Zinc Ahead on May 21, 2015, and provided an update about the current state of guidance from the FDA on the appropriate use of social media by prescription product manufacturers.
While pharma and healthcare companies may be limited by regulatory rules about what they can do with social media marketing, there is plenty they can and many companies have already jumped ahead. Here are some case studies of the best and why they work.
This is the PowerPoint presentation that accompanies Dan Dunlop's social media webinar conducted on October 20, 2009. For more information, visit Dan's blog at http://thehealthcaremarketer.wordpress.com or http://healthcaremarketing.ning.com. For information about Dan's company, Jennings, visit http://www.jenningsco.com.
Healthcare & Social Media: 2009 Trends & StrategyScott Meis
March 2009 presentation to Healthcare Public Relations & Marketing Society - Greater New York (HPRMS). Discussing current social media trends and tips to get started and engaged.
Wondering how to grow your practice in 2011?
Adding social media to your marketing plan can be a fantastic way to acquire new patients, keep existing patients in the loop, and have them all shouting your name from the virtual rooftops!
For more information, contact Monique Ramsey at Cosmetic Social Media at 877-401-5485!
What Every Hospital Communicator Should Say – In 140 Characters or LessRMH Healthcare
Twitter can help connect you with your staff, patients and community. During this presentation, you'll learn the best ways to create an engaging feed.
Featuring Holly Martin (media specialist) and Ryan Hildebrand (web specialist) for RMH Healthcare in Harrisonburg, Va.
This course is aimed at communicators who want to learn how to establish a Twitter voice, set goals and learn how to tie other social media accounts into the feed.
A short overview of social media for the non-specialist health care communications person. Includes practical steps to implement social media and to help your organization adapt to and support social media.
What is Social Media? What are the steps to strategically use to understand social media? What are examples of successful public health case studies? Get the answers to all of the questions above and more during the HRSA Social Media Webcast!
"Brand of You in the Digital Age" - MNAMA+MIMATim Brunelle
This is the presentation Greg Swan and I used to facilitate "The Brand of You in the Digital Age" event on July 9, 2009 for the Minnesota branch of the American Marketing Association. The event was co-sponsored by MIMA.
I spoke to an undergraduate marketing class at SDSU about social media marketing. I was asked to speak about my background, social media marketing, how to set up a social media strategy, some use cases, and how to get a job in social media marketing.
Enabling Business with Social Media Tools at CiscoAyelet Baron
There is a lot of hype about social media right now, which has created some confusion around when to strategically use it. The key is to realize that for any organization, social media is another channel to drive trusted relationships and community interactions. It’s important for any organization to have a plan that maps out their overall journey through a vision, strategy and an executable roadmap.
Similar to Social Media and Pharma Regulatory: Making it Work (20)
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
6. Explosive Social Media growth … Total users 300 million Twitter Unique Visitors … Total users 54 million Facebook Unique Visitors
7. Why should you care about Social Media? It’s here and it’s growing No one should know more about you than you Great opportunity to engage Guidelines are coming… … In the meantime avoid inertia, choose your level of engagement
8.
9. Getting started Build trust by engaging early and consistently with regulatory and legal Ideal More likely Find/develop company social media champions Create strategy Agree on the vision Continue to educate Intranet blogs Internal Twitter Suggestion Box ACTION WITH TRANSPARENCY BUILDS TRUST TRUST DRIVES IMPLEMENTATION Educate and engage internally HR IT Internal Comms Collaborate on in-house practice opportunities Commit to starting
10. Levels of engagement Preclinical Search your company *name *brands *TAs *issues Phase I YouTube Podcasts *Affordable healthcare *Preventing disease *Chronic health problems Disseminate information one way Share what’s useful Phase IIa External blog such as company history (J&J) Test a low-risk topic with external interaction Listen, establish reputation baseline Phase IIb ADHD moms, CML Earth (Novartis), Twitter (Novo Nordisk) Test topic of greater interest for key community interaction Phase III Twitter (BI) External Blog (J&JBTW) External public/company interaction with a personal voice
11. How not to be credible Don’t commit resources No trained staff to maintain engagement Disable social aspects as an automatic reflex Finding AEs Off-label mentions Criticism Second-guess others’ interests Choose topics without regard for what others want Use only a corporate voice Written company statements Press releases Don’t show up Set something up and never go there Be present sporadically
12. How to be credible Be present every day Commit resources for personnel and training Keep information current Be transparent Be clear about what that means Use people’s interests to choose your topics Prevention Chronic health problems Access to healthcare Be personable You know how Take time to build trust Engage consistently over time
13. The business benefit TRANSPARENCY BUILDS TRUST TRUST DRIVES BUSINESS When people trust your brand they buy, recommend, and support what you offer